On Wednesday, Boston Scientific experienced a loss of nearly one-fifth of its market capitalization in a single trading ...

Boston Scientific grew sales and adjusted earnings per share by 16% and 14% in the fourth quarter. However, the company's guidance underwhelmed the market. Ultimately, Boston Scientific's earnings ...

The medical technology giant reported adjusted earnings of 80 cents, beating the consensus of 78 cents and the management guidance of 77-79 cents. Sales increased 15. ...

Feb 4 (Reuters) - Boston Scientific (BSX.N), opens new tab on Wednesday reported lower-than-expected quarterly sales in its key electrophysiology division, dragging the medical device maker's shares ...

Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor expectations. This response was ...

On February 5, Truist lowered its price objective on Boston Scientific Corporation (NYSE:BSX) to $95 from $120. The firm maintained a Buy rating on the stock. In a note to clients, the analyst said ...

The Boston Scientific Analyst: Analyst Mike Matson maintained a Buy rating, but slashed the price target from $121 to $97. The Boston Scientific Thesis: The company reported revenue of $5.286 billion ...

In October, Boston Scientific announced plans to dive into the peripheral nerve stimulation space through the acquisition of medtech company Nalu Medical. Boston Scientific has been a Nalu investor ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The fair value estimate for Boston Scientific has been reset from US$125.45 to ...

Few analysts foresaw the disappointing results and profit forecast that sent Boston Scientific Corp.’s shares plummeting nearly 20% this week. Even fewer have given up on their bullish calls since. It ...

The company's earnings came in at $672 million, or $0.45 per share. This compares with $566 million, or $0.38 per share, last year. Excluding items, Boston Scientific Corp reported adjusted earnings ...